{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:46:49Z","timestamp":1793170009334,"version":"4.5.0"},"reference-count":31,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T00:00:00Z","timestamp":1341532800000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Midwife Womens Health"],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:p>Premature shortening of the cervix, or short cervix, is the most predictive risk factor for preterm birth. Results of clinical studies of interventions to prevent preterm birth have shown that identifying at\u2010risk women on the basis of cervical length versus obstetric history alone improves the likelihood of timely interventions with cervical cerclage or progesterone supplementation, improving outcomes. Debate continues over the use of cerclage; however, results of a meta\u2010analysis of randomized controlled trials provide evidence to support its use in women who have history of prior preterm birth and who develop short cervix before 24 weeks' gestation. Results of the recent PREGNANT trial, consistent with the earlier Fetal Medicine Foundation study, support the use of vaginal progesterone for prevention of preterm birth. In women identified by transvaginal ultrasound to have short cervix (10\u201320 mm) in midtrimester, daily vaginal progesterone gel reduced the risk of preterm birth before 33 weeks' gestation by 45% and before 28 weeks' gestation by 50%. Occurrence of any morbidity and mortality event also was significantly reduced by 43%, with a 61% reduction in the rate of respiratory distress syndrome in infants born to women receiving vaginal progesterone gel versus those receiving placebo. The safety profile of progesterone treatment in early pregnancy is well established, and studies of vaginal progesterone for prevention of preterm birth have identified no additional safety issues. Adverse events were comparable between women receiving progesterone and those receiving placebo. Recent guidelines issued by the American College of Obstetricians and Gynecologists and the Society for Maternal\u2010Fetal Medicine recommend vaginal progesterone in women with no prior spontaneous preterm birth and cervical length of 20 mm or less at 24 weeks' gestation or earlier. Future studies will refine strategies for prevention of preterm birth to address other risk factors and determine the role of other interventions.<\/jats:p>","DOI":"10.1111\/j.1542-2011.2012.00210.x","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T21:33:45Z","timestamp":1341610425000},"page":"12-18","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Treatment Options and Recommendations to Reduce Preterm Births in Women With Short Cervix"],"prefix":"10.1111","volume":"57","author":[{"given":"Joan","family":"Slager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Lynne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,7,6]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.8911"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602293340904"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0705.1998.12050312.x"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0960-7692.2001.00526.x"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.9073"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067815"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31818b1ff6"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3182538e64"},{"key":"e_1_2_8_10_2","article-title":"The Society for Maternal\u2010Fetal Medicine: Publications Committee. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice","author":"Berghella V","year":"2012","journal-title":"Am J Obstet Gynecol."},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31820ca847"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31821fd5b0"},{"issue":"3","key":"e_1_2_8_13_2","first-page":"S150","article-title":"Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin","volume":"90","author":"Practice Committee of the American Society for Reproductive Medicine, Society for Reproductive Endocrinology and Infertility","year":"2008","journal-title":"Fertil Steril."},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2010.01.011"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1989.tb02385.x"},{"key":"e_1_2_8_16_2","unstructured":"American College of Obstetricians and Gynecologists District II.Preventing preterm birth: the role of 17\u03b1 hydroxyprogesterone caproate.http:\/\/mail.ny.acog.org\/website\/17PResourceGuide.pdf. Accessed December 29 2011."},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1990.tb01740.x"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035140"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000281348.51499.bc"},{"key":"e_1_2_8_20_2","unstructured":"United States Food and Drug Administration.FDA approves drug to reduce risk of preterm birth in at\u2010risk pregnant women [press release]. February 4 2011.http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm242234.htm. Accessed December 29 2011."},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.9017"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070641"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.12.042"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31822ad6aa"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)56935-0"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.5158"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.5159"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.7338"},{"key":"e_1_2_8_29_2","article-title":"Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and meta\u2010analysis of individual patient data","author":"Romero R","year":"2011","journal-title":"Am J Obstet Gynecol."},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2009.12.005"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-11-77"},{"key":"e_1_2_8_32_2","unstructured":"Netherlands Trial Register.Preventing preterm birth with progesterone: costs and effects of screening healthy women with a singleton pregnancy for a short cervical length.http:\/\/www.trialregister.nl\/trialreg\/admin\/rctview.asp?TC=2078. Accessed March 14 2012."}],"container-title":["Journal of Midwifery &amp; Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1542-2011.2012.00210.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1542-2011.2012.00210.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T08:33:41Z","timestamp":1694594021000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1542-2011.2012.00210.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":31,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.1111\/j.1542-2011.2012.00210.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1542-2011.2012.00210.x","archive":["Portico"],"relation":{},"ISSN":["1526-9523","1542-2011"],"issn-type":[{"value":"1526-9523","type":"print"},{"value":"1542-2011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"2012-07-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}